Skip to main content

BlackRock, Inc.

Position in TMO — Thermo Fisher Scientific Inc.

CIK 2012383 New York, NY

Position in TMO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$14,955,877,673
-$2,820,422,780 QoQ
Shares Held
30,427,192
-0.8% QoQ
Ownership
8.19%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 90.24289884380725.ToString("F0")% Shared 0.ToString("F0")% None 9.757101156192752.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026
CallValue
$11,550,955
CallShares
23,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $54,004,955,805 across 42 Diagnostics & Research names. TMO ranks #1 (27.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page
30,427,192 $14,955,877,673

All Filings in TMO

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,550,955 23,500
2026-03-31 $14,955,877,673 30,427,192
2025-12-31 $17,776,300,453 30,677,885
2025-09-30 $14,374,846,201 29,637,636
2025-06-30 $11,081,225,031 27,330,008
2025-03-31 $14,470,268,201 29,080,121
2024-12-31 $15,001,264,351 28,835,831
2024-09-30 $18,035,674,552 29,157,047